Acumen Pharmaceuticals, Inc.
ABOS
$2.97
-$0.20-6.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 23.14% | 2.56% | -18.57% | -63.28% | -110.69% |
| Total Depreciation and Amortization | 1.10% | 3.35% | 3.37% | 5.78% | 7.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.43% | 110.79% | 150.57% | 100.11% | 87.00% |
| Change in Net Operating Assets | -81.89% | -141.82% | -143.93% | -98.86% | 122.98% |
| Cash from Operations | 22.06% | -2.99% | -34.01% | -83.70% | -111.72% |
| Capital Expenditure | 100.00% | 89.29% | -450.00% | -193.33% | -137.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.03% | 6.33% | 178.96% | 551.89% | 177.30% |
| Cash from Investing | -8.94% | 6.42% | 178.87% | 551.16% | 177.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | 96,908.11% | 96,908.11% | -99.51% | -99.53% | -99.97% |
| Repurchase of Common Stock | -420.73% | -81.71% | -78.05% | 80.57% | 80.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 91.91% |
| Cash from Financing | 40,865.52% | 16,725.12% | -100.49% | -100.12% | -100.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 172.66% | 228.99% | 158.74% | 122.12% | -243.87% |